DEFA14A

Proxy Materials

CUMBERLAND PHARMACEUTICALS INC Filed 2015-03-13 Acc 0001628280-15-001759

Documents 1

DEFA14A Proxy Materials , a2015proxystatement.htm

Around this filing

2016-03-29 DEFA14A Proxy Materials
2015-03-20 4 Director sold 6,000 shares at $6.95 ($41,700)
2015-03-13 DEFA14A Proxy Materials
2015-03-09 10-K Annual Report

Link to a passage

External

SEC EDGAR (opens in new tab)